Advanced Lipids’ Infat shows strong bone growth potential for infants

c9ebf246-c4b4-4be0-8355-3c121e91a2a7articleimage.jpg

17 Nov 2017 --- Advanced Lipids’ SN-2 infant formula ingredient Infat may have the potential to support healthy bone growth, a study has shown. The study published in Nutrients may be especially interesting for children with special nutritional needs, among others.

Palmitic acid is the most abundant saturated fatty acid in human milk, where it is primarily located in the SN-2 position, Advanced Lipids notes. SN-2 palmitate is a well-established structured fat added to infant formulas. It is already known to offer a range of benefits for babies, including longer sleep duration and reduced crying.

Recently, researchers set out to explore the effect that SN-2 palmitate has on the length and quality of bones in a catch-up growth model. After restricting the diets of two groups of rats, one group was fed with a diet enriched with Infat – Advanced Lipids’ SN-2 palmitate ingredient – and the other with a standard diet.

Weight gain was similar between the two groups and there were no adverse effects from either diet. However, rats in the Infat group scored higher on parameters such as humerus length. Values relating to bone quality also seemed higher in the Infat group, although the difference did not reach statistical significance.

Researchers also analyzed gene expression in the two groups and found that three genes in the liver showed an increase in the Infat group. They say these may be associated with growth and development in the epidermal growth plate.

“Infat is already a well substantiated structured fat for infant formula with multiple clinical studies proving its benefits for infant nutrition,” comments Dr. Sigalit Zchut, Chief Scientist at Advanced Lipids. “However, as an innovative company, Advanced Lipids is testing its effect in other fields as well.”

“This study is exciting because it shows that SN-2 palmitate may have a beneficial effect on the length and quality of bones of mice that were subjected to food restriction, followed by nutrition-induced catch-up growth,” Zchut adds. “Though this is a pre-clinical study, its implications may be important, especially for children with growth disorders and children with special nutritional needs.”

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

GOS holds dietary fiber potential: FrieslandCampina eyes new applications

13 Aug 2018 --- FrieslandCampina is targeting the dietary fiber opportunity for its Galacto-Oligosaccharides (GOS). The move comes in response to the recent FDA green light on specific dietary fibers which presents new market opportunities and application areas. “There is a lot of interest in clean, green and label-friendly ingredients and fiber is one that they are looking for, but in good tasting applications. This really means a lot more flexibility for formulators to offer something that has both prebiotic and fiber benefits,” Sarah Staley of FrieslandCampina tells NutritionInsight on the topic of GOS as a trending prebiotic fiber.

Health & Nutrition News

Soy diets might increase women’s bone strength, suggests animal study

08 Aug 2018 --- Osteoporosis, decreased physical activity and weight gain are serious health concerns for postmenopausal women. Researchers from the University of Missouri now have discovered through a new animal study that soy protein found in food might counter the negative effects of menopause on bone and metabolic health. Moreover, the researchers believe that soy protein might also have positive impacts on bone strength for women who have not yet reached menopause.

Regulatory News

EFSA greenlights novel foods status for Biova’s egg membrane hydrolysate, amid joint health surge

06 Aug 2018 --- The European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) has recognized egg membrane hydrolysate BiovaFlex as novel food pursuant to Regulation (EU) 2015/2283. According to the applicant, Biova LLC (the supplier of BiovaFlex), the ingredient holds particular market potential due to its natural sourcing credentials as well as the convenience it brings by being water-soluble.

Health & Nutrition News

Vitafoods Asia: Functional foods, fortification and bioactivity to be key themes

03 Aug 2018 --- This year’s Vitafoods Asia, to be held in Singapore in September, reports that it will deliver over 300 exhibitors, marking a growth of 40 percent since 2017. This year’s exhibition will cover a range of aspects of the development and application of nutraceuticals, through to product positioning, branding and marketing, inclusive of how to overcome regulatory challenges in various markets, according to the organizers. 

Health & Nutrition News

Whey basic protein isolate safe for use in infant nutrition, EFSA rules

01 Aug 2018 --- Whey basic protein isolate is safe for use in infant and follow‐on formula and meal replacement beverages, dietary foods for special medical purposes and as food supplements, the European Food Safety Authority (EFSA) has concluded. The application for EFSA’s scientific opinion was submitted by French dairy ingedients company Armor Protéines. 

More Articles
URL : http://www.nutritioninsight.com:80/news/advanced-lipids-infat-shows-strong-bone-growth-potential-for-infants.html